|
 |
Clinical Trials in CNS |
|
|
25-26 November 2008
Copthorne Tara Hotel, London, UK
Following last year's success, SMi are proud to present their 7th Annual Clinical Trials in CNS conference which will bring you the latest on clinical trial optimisation, pitfalls and considerations. Don't miss this opportunity to hear the latest developments in CNS clinical trials including:
- The latest in anti-depression drugs and how recent developments have affected current clinical trials
- Discover the newest in imaging analyses: monitoring and predictive capabilities
- Gain insight into patient recruitment for CNS Clinical Trials
- Evaluate the prediction of human efficacy in animal models
Plus a half day post-conference workshop on Assessing Cognitive Enhancement in Clinical Trials, taking place 27th November 2008, Copthorne Tara Hotel, London, UK, in association with: Cognitive Drug Research (CDR)
HOW TO BOOK: To register online simply visit the website: www.smi-online.co.uk/08cnstrials13.asp
Alternatively, contact Zain Philbey, tel: +44 (0) 20 7827 6722 or e-mail: zphilbey@smi-online.co.uk, quoting 'ICT' to receive £100 discount!! |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
BIO-Europe Spring 2009
16-18 March 2009, Milano Convention Centre, Milan, Italy
The BIO-Europe Spring® event brings together international decision-makers from all sectors of the biotechnology industry, and features the successful combination of one-to-one meetings, company presentations, panel discussions and a lively exhibition. Positioned as the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, the BIO-Europe Spring event continues the tradition of providing life science companies with high calibre partnering opportunities. The event enables biotechnology companies to identify, meet and network with companies across the biotechnology value- chain from large biotech and pharma companies to financiers and innovative start-ups.
More info >> |
|
 |
News and Press Releases |
 |
Novozymes Biopolymer Wins Gold Innovation Award for
Novozymes Biopolymer announced winning the Gold Innovation Award at CPhI worldwide conference in Frankfurt, Germany, for its novel form of hyaluronic acid (HA) HyaCare®. The CPhI Innovation Award is established as the showcase for exceptional work in developing research and technology, setting the standards for the pharmaceutical manufacturing industry. The judging panel took into account a number of factors including effective development of the technology and its key benefits to the pharmaceutical industry.
More info >> |
|
|
